IRIS
PAGANI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.252
EU - Europa 1.636
AS - Asia 1.256
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 5.156
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.217
CN - Cina 1.239
IE - Irlanda 489
UA - Ucraina 377
FI - Finlandia 248
DE - Germania 198
SE - Svezia 113
IT - Italia 104
GB - Regno Unito 57
CA - Canada 35
FR - Francia 34
BE - Belgio 9
AU - Australia 7
MY - Malesia 4
VN - Vietnam 4
EU - Europa 3
NL - Olanda 3
IN - India 2
JP - Giappone 2
RU - Federazione Russa 2
SG - Singapore 2
TR - Turchia 2
BR - Brasile 1
ES - Italia 1
HK - Hong Kong 1
HU - Ungheria 1
NZ - Nuova Zelanda 1
Totale 5.156
Salva come PNG Salva come JPEG
Città #
Jacksonville 492
Dublin 488
Chandler 460
Nanjing 378
Nanchang 151
Ashburn 129
Beijing 119
Hebei 116
Wilmington 111
Princeton 109
Lawrence 106
Medford 105
Shenyang 99
Changsha 95
Jiaxing 90
Ann Arbor 64
Tianjin 59
Boardman 49
Helsinki 48
Hangzhou 40
Dearborn 33
New York 31
Toronto 31
Milan 26
Verona 22
Woodbridge 21
Seattle 19
Pavia 17
Kunming 14
Norwalk 14
Shanghai 12
Brussels 9
Fairfield 9
Jinan 8
Des Moines 7
Guangzhou 7
Taizhou 7
Lanzhou 6
Los Angeles 6
Ningbo 6
Houston 5
Zhengzhou 5
Canberra 4
Dong Ket 4
Falls Church 4
San Francisco 4
Turin 4
Melbourne 3
Orange 3
Acireale 2
Changchun 2
Cosenza 2
Costa Mesa 2
Fredericksburg 2
Fuzhou 2
Redmond 2
Singapore 2
Tappahannock 2
Tokyo 2
Washington 2
Altoona 1
Amsterdam 1
Auburn Hills 1
Baotou 1
Brugherio 1
Budapest 1
Cambridge 1
Central 1
Chicago 1
Chieti 1
Chongqing 1
Christchurch 1
Donegal 1
Easton 1
Falkenstein 1
Giarre 1
Haikou 1
Jinhua 1
Kingston 1
London 1
Nanning 1
Pompano Beach 1
Radcliffe 1
Rome 1
Santarcangelo 1
Springdale 1
Temiscaming 1
Torino 1
Windsor 1
Totale 3.700
Salva come PNG Salva come JPEG
Nome #
3-M syndrome associated with growth hormone deficiency: 18 year follow-up of a patient. 81
Growth Hormone Receptor Gene Expression in Puberty. 79
Human lymphocytes as a model for evaluating growth hormone (GH) action in normal and Laron syndrome children 76
Prevelenza dell'associazione del deficit di ormone della crescita (GH) e della celiachia in bambini di bassa statura 72
Ormone della crescita e sistema immunitario 71
Changes in adiponectin and leptin circulating levels during the first year of life in neonates 70
The level of bioavailable growth hormone (GH) after the first GH injection predicts the first year's growth response in GH-deficient children. 69
Accrescimento staturale ed altezza definitiva in bambini con deficit di GH e celiachia 68
Adipokine profile in growth hormone deficient (GHD) children before and after GH treatment 68
Changes in circulating levels of adiponectin and leptin in children during the first two years of life 67
Approccio diagnostico alla bassa statura 67
Development of antibodies against growth hormone (GH) during rhGH therapy in a girl with idiopathic GH deficiency: a case report. 67
Variations in biological and immunological activity of growth hormone during the neonatal period. 66
Abnormal GH receptor signalling and partial GH resistence in a patient with idiopathic short stature 65
Adherence to growth hormone therapy: a practical approach. 65
Human amniotic fluid cells are able to produce IL-6 and IL-8. 63
Effetto dell'ormone della crescita (GH) sui livelli sierici di citochine 63
Biologia molecolare. Il modello del recettore per il GH 63
I ridotti livelli circolanti di IGF-I e GHBP nei bambini pigmei Babinga correlano con la loro bassa statura 63
Serum IGF-I and IGFBP-3 reference values from a chemiluminescent assay in normal children and adolescents of Hispanic and Italian origin: presence of a sexual dimorphism in IGF-I values 61
Development of a novel bioassay for evaluating growth hormone (GH) bioactivity 61
Changes in growth hormone receptor gene expression during therapy in children with juvenile idiopathic arthritis 61
Unreliability of classic provocative tests for the diagnosis of growth hormone deficiency 61
Serum cytokine levels in GH-deficient children during substitutive GH therapy 60
Common adipokine features of neonates and centenarians 60
Diagnosi differenziale tra la sindrome di Bierich e la sindrome di Laron: ruolo del metodo di dosaggio dell'IGF-I 60
Stimulating effect of growth hormone on cytokine release in children 60
Growth hormone system and immune function 59
Association of the (CA)(n) repeat polymorphism of Insulin-like-Growth Factor-I (IGF-I) and -202 A/C IGF Binding Protein-3 (IGFBP3) Promoter Polymorphism with Adult height in patients with severe growth hormone deficiency. 59
A Case of Craniopharyngioma Presenting as Precocious Puberty after a Period of Stunted Growth 59
A 5.8 Mb interstitial deletion on chromosome Xq21.1 in a boy with intellectual disability, cleft palate, hearing impairment and combined growth hormone deficiency 59
Syndrome of GH bioinactivity: myth or reality? 58
Different Long-Term Response to Growth Hormone Therapy in Small- versus Appropriate-for-Gestational-Age Children with Growth Hormone Deficiency. 58
The influence of long-term GH therapy on cytokine release in GHD children 57
Unreliability of classic provocative tests for the diagnosis of growth hormone deficiency. 57
Kinetics of the nuclear traslocation of Stat-5b in immortalized normal control lymphocytes, as studied by immunocytochemistry. Sexual dimorphism of the growth hormone receptor signalling pathway response to rhGH 56
Can growth hormone deficiency diagnosis be affected by the GH immunoassay used? 56
Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders 55
Analysis of growth hormone receptor gene expression in idiopathic tall stature children. 55
Growth hormone isoforms release in response to physiological and pharmacological stimuli. 54
Changes in growth hormone receptor gene expression during therapy in children with juvenile idiopathic arthritis. 54
Breast feeding: gamut of benefits. 54
Circulating GH isoforms and GH bioactivity in preterm neonates. 53
Is BaF3 bioassay useful to identify patients with bioinactive growth hormone? 53
Secular trends in growth of African Pygmies and Bantu 53
Growth hormone receptor exon 6 isophorms influence GH response to dynamic stimulation 53
Development of antibodies against growth hormone (GH) during rhGH therapy in a girl with idiopathic GH deficiency: a case report. 53
Celiac disease and short stature in children. 53
Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment. 52
Diagnosis of growth hormone (GH) deficiency is affected by calibrators used in GH immunoassays. 51
Late diagnosis of celiac disease in an asymptomatic infant with growth failure 51
Biochemical analysis of muscle biopsy in overnight fasting patients with severe chronic heart failure 51
The Pygmy short stature enigma 50
Reference ranges for serum IGF-I and IGFBP-3 by a chemiluminescent assay in children and adolescents. Sexual dimorphism in IGF-I values 50
Growth factors evaluation in Babinga Pygmy from childhood to adulthood 50
Effect of human recombinant growth hormone therapy on circulating levels of erythropoietin and granulocyte-colony stimulating factor in short stature 49
Heterozygous GHR gene mutation in a child with idiopathic short stature 49
Hormona del crecimiento biologicamente inactiva 48
Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling 48
Response to long-term growth hormone therapy in short children with reduced GH bioactivity. 47
Patient with bioinactive growth hormone (GH): growth responce at the 1st year of GH therapy 47
Decreased IGF-I and GHBP circulating levels in Babinga Pygmy children correlate with their stunted growth 47
Effects of growth hormone on natural killer cells 46
Short stature in children with coeliac disease 46
Do celiac children with growth hormone deficiency treated with growth hormone (GH) reach normal final height? 46
Relationship between the endocrine and immune system: reality or mith? 46
GH secretory pattern in non-obese children and adolescents with Prader-Willi sindrome 46
Effect of growth hormone therapy on the proinflammatory cytokine profile in growth hormone-deficient children. 45
Relationship between growth hormone (GH) and the immune system: Myth or realtiy? 45
Effect of human recombinant growth hormone therapy on circulating levels of erythropoietin and granulocyte colony stimulating factor in chort children 45
Kinetics of the nuclear traslocation of STAT-5b in immortalized normal control lymphocytes, as studied by immunocytochemistry 44
Identification of autophagy-related genes and their regulatory miRNAs associated with celiac disease in children 44
The shortness of Pygmies is associated with severe under-expression of the growth hormone receptor 44
Prevalenza dell'associazione del deficit di ormone della crescita (GH) e della celiachia in bambini di bassa statura 43
Efficacy of long-term growth hormone therapy in short non-growth hormone-deficient children 43
Can growth hormone (GH) therapy affect the humoral system in GH-deficient children? 43
Growth retardation in children with celiac disease 42
Growth failure in pediatric tubercular meninigitis. 42
Analysis of growth hormone receptor gene expression in tall and short stature children 42
Indagine conoscitiva sugli interventi organici in corso da parte di istituzioni pediatriche italiane a favore dell'assistenza pediatrica dei paesi in via di sviluppo 42
Growth hormone immunoreactivity does not reflect bioactivity. 41
Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome 41
Dose dependency of the serum bio/immuno GH ratio in children during pharmacological secretion tests. 41
Clinical management of short children with low serum immunoglobulin but no immunodeficiency features 39
Different growth pattern in response to GH therapy in SGA and AGA GH-deficient prepubertal children 37
Omitting duodenal biopsy in children with suspected celiac disease and extra-intestinal symptoms 37
Role of adiponectin and leptin on body development in infants during the first year of life 36
Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. 36
Difetti molecolari nell'asse GH/IGF-I. Ruolo del recettore dell'ormone della crescita 35
Effect of growth hormone (GH) on the immune system 35
Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12 month GH treatment. 34
Tall stature: A difficult diagnosis? 34
Hyperimmunoglobulinaemia in Babinga Pygmies is present from infancy 34
Heterozygous GHR gene mutation in a child with idiopathic short stature. 33
Variations of growth hormone (GH) isoforms during the early postnatal life. 33
Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency Endocrinology 33
Common adipokine features of neonates and centenarians 31
Growth hormone receptor polymorphisms and growth hormone response to stimulation test: a pilot study 31
Respuesta de la hormona de crecimiento (GH) bioactiva sérica a test farmacológicos. Dosis dependencia de la relación bio/inmuno de la GH sérica 30
Relationship between growth hormone and the immune system 27
Totale 5.137
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.847
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 4 1 10
2019/20201.541 430 615 4 70 4 85 10 113 6 169 31 4
2020/2021650 85 59 13 73 2 82 4 104 14 106 89 19
2021/2022466 3 5 28 1 7 29 3 20 35 3 68 264
2022/20231.382 163 95 8 110 142 145 0 93 564 11 37 14
2023/2024397 52 67 10 40 53 131 6 30 1 7 0 0
Totale 5.282